GlassScriptPhysician profile
Christine E Eros
NPI 1982743175
$7,608.20
in general payments reported to CMS, 2019-2025
47 companies · $1,246 in 2025
The $1,246 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,034 · 2020: $1,559 · 2021: $1,224 · 2022: $892 · 2023: $361 · 2024: $292 · 2025: $1,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,899.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $973.45 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $720.01 | 2019-2025 | Breztri, Farxiga |
| Sanofi-Aventis U.S. LLC | $609.98 | 2019-2025 | |
| Glaxosmithkline, LLC. | $609.56 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $556.85 | 2019-2025 | Wegovy, Saxenda, Ozempic |
| Janssen Pharmaceuticals, INC | $479.23 | 2019-2025 | Spravato |
| Amgen INC. | $469.53 | 2019-2025 | Prolia, Evenity, Prolia |
| Pfizer INC. | $327.12 | 2019-2025 | |
| Allergan, INC. | $306.76 | 2019-2020 | |
| Radius Health, INC. | $276.76 | 2019-2025 | Tymlos |
| Astellas Pharma US INC | $248.71 | 2019-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $226.57 | 2019-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $222.93 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $168.35 | 2019-2020 | |
| Sanofi Pasteur INC. | $162.44 | 2019-2025 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Eros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.